Skip to main content
OpenTrials

Clinical trial condition

Stomach Diseases

Explore clinical trials studying Stomach Diseases. Study availability and eligibility vary by location and protocol.

2,581 public trials 586 recruiting studies
Refine in advanced search Browse all conditions

Stomach Diseases trial results

Completed

A Study of Ramucirumab (LY3009806) Plus MEDI4736 in Participants With Advanced Gastrointestinal or Thoracic Malignancies

NCT02572687

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +28 more
Locations
  • UCLA Medical Center Santa Monica, California, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • Washington University Medical Center St Louis, Missouri, United States
  • Carolinas Medical Center Charlotte, North Carolina, United States
View all 28 locations
View Trial Details
Completed

A Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) for TAK-906 in Participants With Diabetes Mellitus and Gastroparesis (DG) or With Idiopathic Gastroparesis (IG)

NCT03268941

Conditions
Diabetes Mellitus, Diabetes Mellitus and Gastroparesis, Idiopathic Gastroparesis, Digestive System Diseases, +11 more
Locations
  • 9171 West Thunderbird Road Peoria, Arizona, United States
  • 850 North Kolb Road Tucson, Arizona, United States
  • 11219 Financial Centre Parkway Little Rock, Arkansas, United States
  • 13055 Southwest 42nd Street Miami, Florida, United States
View Trial Details
Completed

Comparison of Laparoscopic Proximal Gastrectomy and Laparoscopic Total Gastrectomy

NCT02892643

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer, +6 more
Locations
  • Soonchunhyang University Bucheon Hospital Bucheon-si, South Korea
  • Dong-A University Hospital Busan, South Korea
  • Dankook University Hospital Cheonan, South Korea
  • Keimyung University Hospital Daegu, South Korea
View all 16 locations
View Trial Details
Completed

A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Gastroesophageal Junction or Gastric Cancer

NCT01774786

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer, +6 more
Locations
  • Florida Cancer Specialists - SCRI; Pharmacy Fort Myers, Florida, United States
  • University Of Chicago Medical Center; Section Of Hematology/Oncology Chicago, Illinois, United States
  • Indiana University Health; Goshen Center for Cancer Care Goshen, Indiana, United States
  • Comprehensive Cancer Centers of Nevada - Eastern Avenue Las Vegas, Nevada, United States
View all 172 locations
View Trial Details
Completed

SEPREVEN: a Stepped-wedge Randomised Controlled Trial

NCT02598609

Conditions
Catheter-related Bloodstream Infection (CRBSI) Nos, Cross Infection, Digestive System Diseases, +27 more
Locations
  • CHU Strasbourg Hautepierre Strasbourg, Alsace, France
  • CHU Grenoble Grenoble, Auvergne-Rhône-Alpes, France
  • CHU Lille Jeanne de Flandres Lille, Hauts-de-France, France
  • CHU Caen Caen, Normandy, France
View Trial Details
Completed

A Phase I Study of LJM716 in Squamous Cell Carcinoma of Head and Neck, or HER2+ Breast Cancer or Gastric Cancer

NCT01598077

Conditions
Breast Diseases, Breast Neoplasms, Carcinoma, +22 more
Locations
  • University of Chicago Medical Center University of Chicago (16) Chicago, Illinois, United States
  • Massachusetts General Hospital SC-5 Boston, Massachusetts, United States
  • University of Texas/MD Anderson Cancer Center UT MD Houston, Texas, United States
  • University of Utah / Huntsman Cancer Institute Huntsman Salt Lake City, Utah, United States
View Trial Details
Completed

Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors

NCT01576666

Conditions
Advanced Pancreatic Adenocarcinoma, Advanced Solid Tumors, Astrocytoma, +35 more
Locations
  • Cedars Sinai Medical Center SC Los Angeles, California, United States
  • University of California San Francisco UCSF (SC) San Francisco, California, United States
  • H. Lee Moffitt Cancer Center & Research Institute Moffitt 4 Tampa, Florida, United States
  • Dana Farber Cancer Institute Dana SC Boston, Massachusetts, United States
View all 23 locations
View Trial Details

Related conditions